NASDAQ: LABT
Lakewood-Amedex Biotherapeutics Inc.CIK 0002079272 · Pharmaceutical Preparations
10-Q
Filed May 22, 2026
· Period ending Mar 31, 2026
Red flag
LABT discloses material control weaknesses, $11.7K cash at quarter-end, $6.8M emergency raise
5 material changes detected. Sign up free to read the summary.
8-K
Filed Apr 28, 2026
· Period ending Apr 24, 2026
Summary not yet generated.
Partner
Trade LABT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.